NURS 6630C NURS 6630N FINAL EXAM
SPRING PSYCHOPHARMACOLOGIC
APPROACHES TO TREATMENT OF
PSYCHOPATHOLOGY 2024 UPDATED
QUESTIONS
, lOMoAR cPSD| 48519099
Question 1
1 out of 1 points
Parents of a 12-year-old boy want to consider attention deficit
hyperactivity disorder (ADHD) medication for their son. Which medication
would the PMHNP start?
Selected d. All of these could potentially treat their son’s
Answer: symptoms.
Question 2
1 out of 1 points
A patient with hypersexual disorder is being assessed for possible
pharmacologic treatment. Why does the PMHNP prescribe an
antiandrogen for this patient?
Selected d. It will block Answer:
testosterone.
• Question 3
1 out of 1 points
Sandra complains of constipation after being on quetiapine (SEROQUEL)
for several weeks. Constipation is likely caused by the binding of
quetiapine (SEROQUEL) to which receptor?
Selected a. M
Answer: 1
Question 4
1 out of 1 points
, lOMoAR cPSD| 48519099
The PMHNP understands that varenicline (CHANTIX) is an effective way to
assist patients with smoking cessation. Why is this medication effective for
these patients? Selected a. Varenicline is a selective nicotinic
Answer: acetylcholine receptor partial agonist
• Question 5
1 out of 1 points
An 80-year-old female patient diagnosed with Stage II Alzheimer’s has a
history of irritable bowel syndrome. Which cholinergic drug may be the
best choice for treatment given the patient’s gastrointestinal problems?
Selected b. Donepezil
Answer: (Aricept)
• Question 6
1 out of 1 points
Molly is a 52-year-old female that has a diagnosis of fibromyalgia. She
complains of fatigue and cognitive difficulties. Which medication is the
PMHNP most likely to prescribe?
Selected b. Milnacipran
Answer: (SAVELLA)
Question 7
1 out of 1 points
A 71-year-old male patient comes to an appointment with his 65-year-old
wife. They are both having concerns related to her memory and ability to
recognize faces. The PMNHP is considering prescribing memantine
(Namenda) based on the following symptoms:
Selected a. Amnesia, apraxia,
Answer: agnosia